ArticleBMC women's health2025
Can hematological and biochemical parameters clinically predict the diagnosis of deep infiltrating endometriosis?
Article in BMC women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Vitamin D deficiency and pain severity in endometriosis: a phenotype-based retrospective observational study.BMC women's health · 2026Observational
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo investigate whether preoperative laboratory biomarkers can differentiate deep infiltrative endometriosis (DIE) from other endometriosis (OE) phenotypes (ovarian, tubal, peritoneal) non-invasively.
methodsThis retrospective case-control study analyzed data from patients operated for pathologically confirmed endometriosis at Kartal Dr. Lütfi Kırdar City Hospital between January 2015 and January 2025. Patients were divided into the DIE group (n = 286) and the OE group (n = 230). Demographic, clinical characteristics, and preoperative laboratory parameters, including complete blood count, neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), cancer antigen 125 (CA125), ferritin, serum iron, TIBC, albumin, and the hemoglobin-albumin-lymphocyte-platelet (HALP) index, were compared between the groups.
resultsPatients in the DIE group reported significantly higher rates and severity of dysmenorrhea, dyspareunia, and chronic pelvic pain compared to the OE group (p < 0.05). Preoperatively, the DIE group had significantly higher CA125 and NLR levels (p < 0.001 for both). Conversely, lymphocyte counts, hemoglobin levels, ferritin levels, and the HALP index were significantly lower in the DIE group (p = 0.003, p = 0.001, p < 0.001, and p < 0.001, respectively). No significant differences were found between the groups regarding age, BMI, WBC, neutrophil, platelet, MPV, PLR, serum iron, TIBC, or albumin levels (p > 0.05).
conclusionsSpecific laboratory biomarkers, notably CA125, NLR, lymphocyte count, hemoglobin, ferritin, and the HALP index, show significant differences between patients with DIE and OE. While no single marker is sufficient for definitive diagnosis, these findings suggest that a combination of these parameters may hold potential for non-invasively assessing the risk of deep infiltrative disease, potentially aiding in preoperative planning and patient counseling. Further prospective validation studies are warranted. These combined biomarkers could assist clinicians in triaging patients for advanced imaging or referral to tertiary endometriosis centers before surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.